13FPulse
中
IR

IRWD IRONWOOD PHARMACEUTICALS INC

2026Q2 · CUSIP 46333X108 · Sector: Healthcare & Biotech

Funds left

Funds are exiting, but the price is holding

Funds that own it
210
Institutions that reported holding it to the SEC
Net decrease in holders
13
Last quarter 223 → now 210
How unusual is that
Bottom 20%
Stronger than only 11% of US stocks
What the filings say, in one paragraph

210 funds held IRWD at the end of 2026Q2, down 13 from the quarter before. Buying has faded, though the price is holding up. On the business itself, revenue over the last 12 months was $389M(YoY +26.2%), the P/E is 5.5x. IRWD has had 9 buying rushes in its history, and the price moved -7.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2013Q3: holders=119 2013Q4: holders=117 2014Q1: holders=135 2014Q2: holders=133 2014Q3: holders=137 2014Q4: holders=128 2015Q1: holders=139 2015Q2: holders=136 2015Q3: holders=129 2015Q4: holders=135 2016Q1: holders=134 2016Q2: holders=145 2016Q3: holders=152 2016Q4: holders=161 2017Q1: holders=162 2017Q2: holders=165 2017Q3: holders=147 2017Q4: holders=156 2018Q1: holders=149 2018Q2: holders=148 2018Q3: holders=150 2018Q4: holders=144 2019Q1: holders=156 2019Q2: holders=151 2019Q3: holders=164 2019Q4: holders=196 2020Q1: holders=191 2020Q2: holders=201 2020Q3: holders=189 2020Q4: holders=199 2021Q1: holders=210 2021Q2: holders=210 2021Q3: holders=229 2021Q4: holders=212 2022Q1: holders=218 2022Q2: holders=237 2022Q3: holders=246 2022Q4: holders=250 2023Q1: holders=253 2023Q2: holders=251 2023Q3: holders=248 2023Q4: holders=250 2024Q1: holders=259 2024Q2: holders=228 2024Q3: holders=220 2024Q4: holders=222 2025Q1: holders=200 2025Q2: holders=158 2025Q3: holders=167 2025Q4: holders=200 2026Q1: holders=223 2026Q2: holders=210 -42 -21 +0 +21 +42 105189272 13Q315Q116Q318Q119Q321Q122Q324Q125Q326Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 9 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 20% — —
2025Q4 Top 20% -15.0% —
2022Q3 Top 20% +5.2% -7.0%
2022Q2 Top 10% -2.6% -3.8%
2021Q3 Top 10% -12.8% -5.8%
2019Q4 Top 20% -7.7% -17.5%
2019Q3 Top 20% +4.9% +3.9%
2015Q1 Top 20% -18.7% -17.0%
2014Q1 Top 20% -3.2% -4.5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
116
Change in large funds
-1
Total value they hold
$676M
Funds buying for the first time
27
Funds that sold out entirely
40
Price change that quarter
+21.4%
Funds holding puts (bearish)
4
Funds holding calls (bullish)
3

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
5.5
EPS (TTM)
$0.77
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+26.2%
Net margin
33.4%
ROE
—
Debt ratio
—
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS 0.34 2021-12-31: EPS 0.25 2022-03-31: EPS 0.21 2022-06-30: EPS 0.21 2022-09-30: EPS 0.28 2022-12-31: EPS 0.27 2023-03-31: EPS 0.25 2023-06-30: EPS -6.84 2023-09-30: EPS 0.09 2023-12-31: EPS -0.01 2024-03-31: EPS -0.03 2024-06-30: EPS -0.01 2024-09-30: EPS 0.02 2024-12-31: EPS 0.01 2025-03-31: EPS -0.23 2025-06-30: EPS 0.14 2025-09-30: EPS 0.23 2025-12-31: EPS -0.01 2026-03-31: EPS 0.24 2026-06-30: EPS 0.31 0M 66M 131M $M -7.52 -3.57 0.37 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 12 5 59 113 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-46M17M80M 20162017201820192020202120222023202420252026
Latest quarter $75M (2025-12-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.